Dr. Karolina Edlund

Scientific staff

Head of department
Prof. Dr. Jan G. Hengstler
Monika Turajski
Ardeystr. 67
44139 Dortmund

Here you will find the Publications from 2010 onwards that were produced at IfADo.

Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters. Mod Pathol 30: 964-977 (2017)
Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer. J Cancer Res Clin Oncol 143: 1123–1131 (2017)
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer. Breast Cancer Res Treat 165: 293-300 (2017)
Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma. Cancer Res 77: 4589-4601 (2017)
Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer. PLoS One 12(11): e0187246 (2017) (23 pp)
The protein kinase LKB1 negatively regu-lates bone morphogenetic protein receptor signaling. Oncotarget 7: 1120-1143 (2016)
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer. BMC Cancer 16: 603 (2016) (15 pp)
Profiling cancer testis antigens in non-small-cell lung cancer. JCI Insight 1 (10): e86837 (2016) (17 pp)
Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue. Arch Toxicol 90: 2513-2529 (2016)
Epsin family member 3 and ribosome-related genes are associated with late metastasis in estrogen receptor-positive breast cancer and long-term survival in non-small cell lung cancer using a genome-wide identification and validation strategy. PLoS One 11(12): e0167585 (2016)
The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling. J Gastroenterol 50: 46-57 (2015)
Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer. BMC Cancer 15: 125 (2015) (11 pp)
Tissue-based map of the human proteome. Science 347 (6220): 1260419 (2015)
Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? Expert Rev Mol Diagn 15: 471-490 (2015)
LRIG1 is a prognostic biomarker in non-small cell lung cancer. Acta Oncol 54: 1113-1119 (2015)